Literature DB >> 1460426

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

K Inaba1, M Inaba, N Romani, H Aya, M Deguchi, S Ikehara, S Muramatsu, R M Steinman.   

Abstract

Antigen-presenting, major histocompatibility complex (MHC) class II-rich dendritic cells are known to arise from bone marrow. However, marrow lacks mature dendritic cells, and substantial numbers of proliferating less-mature cells have yet to be identified. The methodology for inducing dendritic cell growth that was recently described for mouse blood now has been modified to MHC class II-negative precursors in marrow. A key step is to remove the majority of nonadherent, newly formed granulocytes by gentle washes during the first 2-4 d of culture. This leaves behind proliferating clusters that are loosely attached to a more firmly adherent "stroma." At days 4-6 the clusters can be dislodged, isolated by 1-g sedimentation, and upon reculture, large numbers of dendritic cells are released. The latter are readily identified on the basis of their distinct cell shape, ultrastructure, and repertoire of antigens, as detected with a panel of monoclonal antibodies. The dendritic cells express high levels of MHC class II products and act as powerful accessory cells for initiating the mixed leukocyte reaction. Neither the clusters nor mature dendritic cells are generated if macrophage colony-stimulating factor rather than granulocyte/macrophage colony-stimulating factor (GM-CSF) is applied. Therefore, GM-CSF generates all three lineages of myeloid cells (granulocytes, macrophages, and dendritic cells). Since > 5 x 10(6) dendritic cells develop in 1 wk from precursors within the large hind limb bones of a single animal, marrow progenitors can act as a major source of dendritic cells. This feature should prove useful for future molecular and clinical studies of this otherwise trace cell type.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1460426      PMCID: PMC2119469          DOI: 10.1084/jem.176.6.1693

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

Review 1.  The surface of dendritic cells in the mouse as studied with monoclonal antibodies.

Authors:  R Agger; M T Crowley; M D Witmer-Pack
Journal:  Int Rev Immunol       Date:  1990       Impact factor: 5.311

2.  Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood.

Authors:  C D Reid; P R Fryer; C Clifford; A Kirk; J Tikerpae; S C Knight
Journal:  Blood       Date:  1990-09-15       Impact factor: 22.113

3.  A monoclonal antibody specific for mouse dendritic cells.

Authors:  M C Nussenzweig; R M Steinman; M D Witmer; B Gutchinov
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

4.  Dendritic cells from mouse bone marrow: in vitro differentiation using low doses of recombinant granulocyte-macrophage colony-stimulating factor.

Authors:  C Scheicher; M Mehlig; R Zecher; K Reske
Journal:  J Immunol Methods       Date:  1992-10-02       Impact factor: 2.303

5.  Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice.

Authors:  R M Steinman; M D Witmer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Identification and characterization of the monoblast in mononuclear phagocyte colonies grown in vitro.

Authors:  T J Goud; C Schotte; R van Furth
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

7.  Identification of proliferating dendritic cell precursors in mouse blood.

Authors:  K Inaba; R M Steinman; M W Pack; H Aya; M Inaba; T Sudo; S Wolpe; G Schuler
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

8.  Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro.

Authors:  R M Steinman; G Kaplan; M D Witmer; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

9.  Bone marrow origin of Ia-positive cells in the medulla rat thymus.

Authors:  A N Barclay; G Mayrhofer
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

10.  Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli.

Authors:  S S Rabinowitz; S Gordon
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  1167 in total

1.  A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse.

Authors:  J Strid; L Lopes; J Marcinkiewicz; L Petrovska; B Nowak; B M Chain; T Lund
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  Identification of progenitor cells in long-term spleen stromal cultures that produce immature dendritic cells.

Authors:  H L Wilson; K Ni; H C O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus.

Authors:  SangKon Oh; J Michael McCaffery; Maryna C Eichelberger
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 4.  The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells.

Authors:  H Singh-Jasuja; N Hilf; H U Scherer; D Arnold-Schild; H G Rammensee; R E Toes; H Schild
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

5.  Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery.

Authors:  W Asavaroengchai; Y Kotera; J J Mulé
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

6.  Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells.

Authors:  A George-Chandy; K Eriksson; M Lebens; I Nordström; E Schön; J Holmgren
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy.

Authors:  J H Shaw; V R Grund; L Durling; H D Caldwell
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

8.  In situ characterization of genetically targeted (green fluorescent) single cells and their microenvironment in an adoptive host.

Authors:  F Leithäuser; Z Trobonjaca; J Reimann; P Möller
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

9.  Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection.

Authors:  A George-Chandy; N Mielcarek; I Nordström; J Holmgren; K Eriksson
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

10.  Evidence for lipopolysaccharide-induced differentiation of RAW264.7 murine macrophage cell line into dendritic like cells.

Authors:  Rajiv K Saxena; Val Vallyathan; Daniel M Lewis
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.